Spots Global Cancer Trial Database for Cancer Panel From Blood of Lung Cancer Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Cancer Panel From Blood of Lung Cancer Patients

Official Title: Clinical Validity of Oncogenic Driver Genes Detected From Circulating Tumor DNA in Blood of Lung Cancer Patients

Study ID: NCT03235765

Conditions

Non Small Cell Lung Cancer Metastatic

Non Small Cell Lung Cancer Recurrent

Interventions

MACROGEN Pan Cancer Panel (Tier 2)

Study Description

Brief Summary: Molecular profiling of lung cancers using circulating tumor DNA (ctDNA) in the blood of patients is rapidly becoming established as a useful source of information to aid clinical decision-making. This study is aimed to to compare concordance rate between tissue based cancer panel analysis and blood based cancer panel analysis in lung cancer patients (both by NGS technique).

Detailed Description: This study is comprised of two cohorts as below: Cohort A: inoperable, untreated, non-small cell lung cancer patients Cohort B: non-small cell lung cancer patients who are in the treatment with targeted agents including immune checkpoint inhibitors